Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).

Belinda LennoxKsenija YeelesPeter B JonesMichael S ZandiEileen JoyceLy-Mee YuGiuliano TomeiRebecca PollardSally-Anne VincentMio ShimazakiIona CairnsFrancis DowlingThomas KabirThomas R E BarnesAnne Lingford HughesAkram A HosseiniTimothy HarrowerCamilla BuckleyAlasdair J Coles

Published in: Trials (2019)

ISRCTN, 11177045. Registered on 2 May 2017. EudraCT, 2016-000118-31. Registered on 22 November 2016. ClinicalTrials.gov, NCT03194815. Registered on 21 June 2017.

Keyphrases

study protocol
double blind
clinical trial
placebo controlled
randomized controlled trial
open label
phase iii
high dose
low dose
hodgkin lymphoma
combination therapy